Early phase 1Not yet recruiting

Topical Insulin Therapy for Persistent Corneal Epithelial Defects

Sponsor
Massachusetts Eye and Ear Infirmary (Academic or other)
Enrollment
40 planned
Conditions
Persistent Corneal Epithelial Defect
Interventions
Insulin Treatment Arm; Control Arm - standard of care
Ages
adults, older adults
Registry
NCT07950527

Full record on ClinicalTrials.gov

From the registry

The goal of this clinical trial is to learn if insulin eye drops, added to standard care, can treat persistent corneal epithelial defects (PEDs) in adults age 18 and older. A PED is a corneal surface wound, at least 2 mm across, that has not healed after more than 14 days of standard treatment such as lubricants, antibiotic drops, or a bandage contact lens. The main question it aims to answer is: \- Does adding insulin eye drops (1 IU/mL, four times daily) to standard care increase the proportion of eyes with complete corneal epithelial healing at 8 weeks? The standard care plus insulin eye drops will be compared to standard care plus placebo eye drops (preservative-free saline) to see if insulin leads to more complete healing, faster healing, fewer recurrences, and better symptom relief. They will also assess the safety of the drops and their effects on corneal nerves. Participants will: * Be randomly assigned (1:1) to insulin or placebo drops. Neither participants nor the investigators assessing healing will know which drops are used. The study is single-center (Massachusetts…

Primary outcomes

  • Complete PED closure rate at 8 Weeks

History

  1. Study completion expected

  2. Primary completion expected

  3. Registered

  4. Started